Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial)
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—We sought to study the optimal management of hyperglycemia in non–intensive care unit patients with type 2 diabetes, as few studies thus far have focused on the subject. RESEARCH DESIGN AND METHODS—We conducted a prospective, multicenter, randomized trial to compare the efficacy and safety of a basal-bolus insulin regimen with that of sliding-scale regular insulin (SSI) in patients with type 2 diabetes. A total of 130 insulin-naive patients were randomized to receive glargine and glulisine (n = 65) or a standard SSI protocol (n = 65). Glargine was given once daily and glulisine before meals at a starting dose of 0.4 units · kg−1 · day−1 for blood glucose 140–200 mg/dl or 0.5 units · kg−1 · day−1 for blood glucose 201–400 mg/dl. SSI was given four times per day for blood glucose >140 mg/dl. RESULTS—The mean admission blood glucose was 229 ± 6 mg/dl and A1C 8.8 ± 2%. A blood glucose target of <140 mg/dl was achieved in 66% of patients in the glargine and glulisine group and in 38% of those in the SSI group. The mean daily blood glucose between groups ranged from 23 to 58 mg/dl, with an overall blood glucose difference of 27 mg/dl (P < 0.01). Despite increasing insulin doses, 14% of patients treated with SSI remained with blood glucose >240 mg/dl. There were no differences in the rate of hypoglycemia or length of hospital stay. CONCLUSIONS—Treatment with insulin glargine and glulisine resulted in significant improvement in glycemic control compared with that achieved with the use of SSI alone. Our study indicates that a basal-bolus insulin regimen is preferred over SSI in the management of non–critically ill, hospitalized patients with type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intensive targets result in hypoglycemia, which, in turn, results in higher complications.105,106”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [105]
In the citing paper
“Most persons with T2D and all persons with T1D in the ICU receiving IV insulin infusion will require transition to a subcutaneous insulin regimen.105”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [105]
In the citing paper
“Persons with T2D receiving insulin therapy before admission are at risk for severe hyperglycemia in the hospital if insulin therapy is discontinued.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [105]
In the citing paper
“BBI is widely accepted and recommended as intensive insulin therapy in DM.42 51 52”
In the citing paper
“It is important to note that the patients in this study were obese, and the doses used in this study (0.4 to 0.5 units · kg · day−1) are higher than what may be required in patients who are more sensitive to insulin, such as those who are lean or who have type 1 diabetes.”
From Standards of Medical Care in Diabetes—2009 (2009) · cites this paper as [342]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationManagement of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Krinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165
Furnary, A. P., Gao, G., Grunkemeier, G. L., Wu, Y., Zerr, K. J., Bookin, S. O., Floten, H. S., & Starr, A. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2003.181 · Cited by 1,130
Glucose Control and Mortality in Critically Ill Patients
Finney, S. J. (2003) · JAMA · doi:10.1001/jama.290.15.2041 · Cited by 1,055
Early Postoperative Glucose Control Predicts Nosocomial Infection Rate in Diabetic Patients
Pomposelli, J. J., Baxter, J. K., Babineau, T. J., Pomfret, E. A., Driscoll, D. F., Forse, R. A., & Bistrian, B. R. (1998) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719802200277 · Cited by 700
Hyperglycemic Crises in Adult Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., & Kreisberg, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-9916 · Cited by 512
Self-citationImplementation of a Safe and Effective Insulin Infusion Protocol in a Medical Intensive Care Unit
Goldberg, P. A., Siegel, M. D., Sherwin, R. S., Halickman, J. I., Lee, M., Bailey, V. A., Lee, S. L., Dziura, J. D., & Inzucchi, S. E. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.461 · Cited by 483
Cited by
Items 601–672 of 672
Leurcharusmee, P., Kositratna, G., Tran, D. Q. H., & Schricker, T. (2017) · Asian Biomedicine · doi:10.1515/abm-2018-0014
Current Treatment of DKA: A Review and Approach to Establishing a Best Practice Protocol
Qually, M. (2015) · Mspace (University of Manitoba)
Williams, J. (2017) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/zywr-jq33
Herr, L., & Thiamwong, L. (2018) · Walailak Journal of Science and Technology (WJST) · doi:10.48048/wjst.2019.3980
Tauseef, M. A., Arshad, M., & Zeb, S. (2015) · Journal of Gandhara Medical and Dental Science · doi:10.37762/jgmds.1-2.66
Yu, X., Zhang, L., Yu, R., Yang, J., & Zhang, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230123
Ojeda, M. M. (2020) · medRxiv · doi:10.1101/2020.05.26.20113936
Hyperglycemia In Hospitalized Patients
Yavuz, D. G., Yazıcı, D., Özcan, S., Tarçın, Ö., Deyneli, O., & Akalın, S. (2013) · Marmara medical journal · doi:10.5472/mmj.2013.02703.1 · Cited by 4
PERI-OPERATIVE MANAGEMENT IN DIABETES MELLITUS
Sakthi Vignesh, G., & Nithianandam, S. (2020) · Indian Journal Of Applied Research · doi:10.36106/ijar/0600810
A Review on Basal Bolus Regimen in Type 1 and Type 2 Diabetes Mellitus.
Eldhoes, A. M., Amurtha Antony, P., Jose, I., Varghese, A., & Krishnakumar, K. (2020) · American Journal of PharmTech Research · doi:10.46624/ajptr.2020.v10.i6.006
Lalwani, D., Muley, A., & Mahida, H. (2021) · Current Medical Issues · doi:10.4103/cmi.cmi_107_20
Glycemic control in non-critically hospitalized patients in tertiary hospitals in northeast Brazil
Janja, M. M. L., Regadas, C. M., Ximenes, F. A. M. B., Andrade, T. G., Vasconcelos, M. M. L. M., Castelo, M. H. C. G., & Ponte, C. M. M. (2021) · Journal of Health & Biological Sciences · doi:10.12662/2317-3076jhbs.v9i1.3453.p1-7.2021
Comparison of various basal insulin dose adjustments for inpatients while unable to eat
Eberhard, C. M., & Petite, S. E. (2021) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-021-01314-2
Gracia‐Ramos, A. E., Cruz-Domínguez, M. P., & Madrigal‐Santillán, E. (2021) · Revista Clínica Española · doi:10.1016/j.rce.2021.09.002
Current literature in diabetes
(2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.879
Basal-bolus insulin regimen is effective for hospitalized patients with type 2 diabetes
(2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0655
(2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282fba8b4
Perez-Belmonte, L. M., Osuna‐Sánchez, J., Rico-Robles, J. I., Ricci, M., Lara, J. P., & Gómez‐Huelgas, R. (2022) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2021.02.022
Prise en charge du diabète en milieu hospitalier
(2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.03.417
Management of Hyperglycaemia in the Hospital Setting
(2012) · Chettinad Health City Medical Journal · doi:10.36503/chcmj1(4)-09
Managing the complex insulin needs of patients during care transitions
(2014) · Pharmacy Today · doi:10.1016/s1042-0991(15)30720-9
Dangodara, A. A., & Muluk, V. S. (2011) · Springer eBooks · doi:10.1007/978-0-85729-498-2_22
Management of Diabetes and Hyperglycemia in the Hospital Setting
DeMauro-Jablonski, S., & Inzucchi, S. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_47
Bloomgarden, Z. T. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12965
Management of the inpatient with diabetes mellitus
McNally, P. G., & Hammersley, M. S. (2011) · doi:10.1093/med/9780199235292.003.1482
Signo, M. (2019) · San José State University ScholarWorks (San Jose State University) · doi:10.31979/etd.ecat-qcw3
Management of Diabetes and Hyperglycemia in the Hospital Setting
DeMauro-Jablonski, S., & Inzucchi, S. E. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_47-1
Effect of Hospital Admission on Glycemic Control One Year after Discharge
Wei, N., Grant, R. W., Nathan, D. M., & Wexler, D. J. (2011) · The Endocrine Society eBooks · doi:10.1210/endo-meetings.2011.part4.p3.p3-451
Diggs, F. J., & Lee, P. H. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.inpatienthyperglycemia_overview
Kuchay, M. S., Mathew, A., Mishra, M., Parvathi, S., Kaur, P., Wasir, J. S., Gill, H. K., Jain, R., Gagneja, S., Kohli, C., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4137357
Silverstein, N., & Sheppard, R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2229-1.00006-1
Inpatient Management of Diabetes and Hyperglycemia
Horton, W. B. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_46 · Cited by 1
Aguilar, E. O., Salas-Delgado, A., Llamas, S. H., Andrew, H. V. P., & González, F. J. L. (2023) · International Journal of Health Science · doi:10.22533/at.ed.1593422302061
de Souza, A. B. C. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-17042023-113357 · Cited by 1
Medical Management of the Limb Salvage Inpatient
Alternburg, M. M., Haydek, J. M., Kiparizoska, S., Weaver, N. K., & Wheeler, M. G. (2023) · Springer eBooks · doi:10.1007/978-3-031-27725-2_8
อัตราการเสียชีวิตที่ 1 ปีของผู้ป่วยโรคหลอดเลือดหัวใจตีบฉับพลันแบบเอสทียกในแต่ละระดับของไขมันแอลดีแอล
หลายชูไทย, ณ. (2016) · Chula Digiverse · doi:10.58837/chula.the.2016.1261
Manejo de la hiperglucemia en pacientes diabéticos hospitalizados en la sala general
Gonzalez, J. G. (2023) · REVISTA ARGENTINA DE MEDICINA · doi:10.61222/ram.v11i3.870
Zhang, X., Yan, D., Du, T., Zhao, Y., Zhang, J., Zhang, T., Lin, M., Li, Y., & Li, W. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01193-9 · Cited by 1
Hyperglycemia and Diabetes in the Posttransplant Patient
Dowlatshahi, S., Zahid, M., & Sadhu, A. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-44648-1_20
The History of Inpatient Diabetes
Brooks, D., Schulman‐Rosenbaum, R., Galindo, R. J., & Umpierrez, G. E. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-44648-1_1
Self-citationDiabetes Care in the Oncologic Population
Presswala, L. S., Farooki, A., & Flory, J. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-44648-1_24
Efficacy and Safety of Dpp-4 Inhibitor Use in the Hospital SettingPreprint
Dass, B. (2024) · doi:10.28971/532024db66
Glycaemic outcomes in hospital with IDegAsp versus BIAsp30 premixed insulins
Walt, J. R., Loughran, J., Fourlanos, S., Barmanray, R., Zhu, J., Varadarajan, S., & Kyi, M. (2024) · Internal Medicine Journal · doi:10.1111/imj.16391
Chiang, H.-H., Kahn, S. E., & Hirsch, I. B. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0120
Sanjeevani, M., Alex, M., Sreedharan, D. P., Vinay, B. C., Supriya, P. S., Bhandari, R., & Kolar, R. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01397-3
Turnsaket, S., Panitchote, A., Chareonsri, S., Pongchaiyakul, C., Ketdao, N., Daewtrakulchai, P., Phunmanee, A., & Patjanasoontorn, B. (2024) · Clinical Critical Care · doi:10.54205/ccc.v32.268831
Elevated Glucose on Admission Fingerstick: How High Can We Go?
Carafone, L. E., Bauer, C. E., Miller, J. D., & Wittlin, S. D. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780190902001.003.0029
Van, K., Ma, X. W., Loughran, J., Brown, A., Lindsey, S., Wong, H., Fourlanos, S., Varadarajan, S., & Kyi, M. (2025) · Internal Medicine Journal · doi:10.1111/imj.70018
Prescription for Prevention: A Focus on Preventing Complications in the ICU
Spezzano, K. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-77335-8_42
Glycemic Control in the Intensive Care Unit
Grucz, T. M., DiCesare, M. A., & Sugrue, D. (2025) · Springer eBooks · doi:10.1007/978-3-031-77335-8_52
Velasco, M. Á. P., Osuna‐Sánchez, J., Millán‐Gómez, M., Ricci, M., Sampalo, A. L., Bernal-López, M. R., Gómez‐Huelgas, R., & Perez-Belmonte, L. M. (2025) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2024.10.023 · Cited by 2
Jha, S. C., & Panchal, H. A. (2025) · International Surgery Journal · doi:10.18203/2349-2902.isj20251536
Abdallah, N., Giuliano, C. A., Rukat, C. E., & Barnes, B. J. (2025) · Hospital Pharmacy · doi:10.1177/00185787251352168
Alvarez, G., Hopkins, A. J., & Farkas, A. (2025) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2025.320
Management of Diabetes and Hyperglycemia in the Hospital Setting
DeMauro-Jablonski, S., & Inzucchi, S. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_47
Predicting optimal insulin dose for diabetes inpatients by using reinforcement learning
Σωτηρίου, Δ., & Sotiriou, D. (2023) · Institutional Repository Hellanicus · doi:10.26215/heal.uoa.6333
Dr. Shakeel Ahmad, D. S. K. (2018) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.1407496
Ramos, A. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Passarella, P., & Gosmanov, A. R. (2025) · Medical Clinics of North America · doi:10.1016/j.mcna.2025.11.001 · Cited by 1
Hasan, S. Y., Al-Wasiti, E., & Jawad, R. A. M. (2025) · Journal of Progressive Medical Sciences · doi:10.63939/at7x0m63
Candia, D. S., Gil, M. X. M., Nieto, A. J., & Sánchez, L. P. C. (2023) · Repositorio Institucional Universidad El Bosque · Cited by 1
White, A. A., & Wisse, B. E. (2026) · Applied Clinical Informatics · doi:10.1055/a-2838-8292
Flint, K. L., Fahey, A., Longo, R. R., Fan, W., Doytchinov, A., Ashley, A. L., Zheng, H., Steiner, B. A., Russell, S. J., & Putman, M. S. (2026) · Diabetologia · doi:10.1007/s00125-026-06737-y
Glycemic Control Practices in Intensive Care Units: A National Survey Study
Kaya, Z. I., & Efe, S. (2026) · Cerasus journal of medicine. · doi:10.70058/cjm.1887013
Cheung, N. W., Hor, A., Marschner, S. L., Chan, C., Min, H., Lee, L., Hng, T., Rhou, Y. J. J., Wu, Y., Wang, M., et al. (2026) · Diabetology · doi:10.3390/diabetology7050094
Insulin Management in the Inpatient Setting: A Comprehensive Review
Sirkin, N. J. (2026) · International Journal of Diabetes & its Complications · doi:10.64030/2573-8895.04.02.01
Osawa, H., Obi, K., Rahman, M., & Noto, H. (2026) · Internal Medicine · doi:10.2169/internalmedicine.7564-26
Shao, L., Li, Y., Wang, L., & Sun, W. (2026) · medRxiv · doi:10.64898/2026.09.28.26364145
Guerrero, L. E. M. (2015) · African Journal of Biomedical Research · doi:10.53555/ajbr.v18i1.10053
The Use of Diabetes Technology in the Inpatient Setting
Akcan, T., Faulds, E. R., Lal, R., Davis, G. M., Brown, S. A., Pasquel, F. J., & Hughes, M. S. (2026) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2026.08.016
Bahru, Y. D., Berha, A. B., Ahmed, A., & Chelkeba, L. (2026) · Research Square · doi:10.21203/rs.3.rs-10815003/v1
Harnessing endocrine physiology for better clinical outcomes
Davis, S. N., Manko, G. A., & Renda, S. (2008) · Clinical cornerstone · doi:10.1016/s1098-3597(08)80005-1
Metadata
- Authors
- Umpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R.
- Affiliations
- Emory University (US)
- University of Miami (US)
- Emory University School of Medicine, Atlanta, Georgia
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-09-01
- Volume
- 30
- Issue
- 9
- Pages
- 2181-2186
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2153098857
- Cited by
- 671
- References
- 30
- Citations by year
- 2026: 17 · 2025: 26 · 2024: 17 · 2023: 22 · 2022: 31 · 2021: 29 · 2020: 34 · 2019: 31 · 2018: 38 · 2017: 33 · 2016: 35 · 2015: 55 · 2014: 50 · 2013: 43 · 2012: 51
- FWCI
- 27.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sanofi
- National Institute of Diabetes and Digestive and Kidney Diseases (R03DK073190)
- National Center for Research Resources (M01-RR00039, M01RR000039)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, multiple daily insulin injections, sliding scale insulin, glargine, glulisine, hyperglycemia management, glycemic control, hypoglycemia, hospitalized patients, insulin-naive patients, glycemic targets
- MeSH terms
- Insulin Glargine, Adult, Aged, Diabetes Mellitus, Type 2, Female, Hospitalization, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Male, Middle Aged, Prospective Studies, Treatment Outcome, Insulin, Long-Acting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.